SUMF2

protein-coding

sulfatase modifying factor 2

Gene summary

The catalytic sites of sulfatases are only active if they contain a unique amino acid, C-alpha-formylglycine (FGly). The FGly residue is posttranslationally generated from a cysteine by enzymes with FGly-generating activity. The gene described in this record is a member of the sulfatase-modifying factor family and encodes a protein with a DUF323 domain that localizes to the lumen of the endoplasmic reticulum. This protein has low levels of FGly-generating activity but can heterodimerize with another family member - a protein with high levels of FGly-generating activity. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]

MANE transcript

NM_015411.4

Inheritance

—

ClinVar variants

P:1U:80B:5

Top phenotype

SUMF2-related disorder

gnomAD constraint

pLI —, LoF o/e 0.82

Max pathogenic AF

—

Genomic locus

chr7:56,064,002-56,080,670

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~16.7 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

No GenCC data available for this gene.

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to SUMF2 variants in ClinVar

4 Conditions Cataloged
not specifiedTotal: 65
not providedTotal: 4
SUMF2-related disorderTotal: 3
Multiple sulfatase deficiencyTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_015411.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
8
clinvar
8
missense
61
clinvar
4
clinvar
65
nonsense
1
clinvar
1
start loss
0
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
10
clinvar
11
Total10804186
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 99 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_015411.4RefSeqNP_056226.39MANE Select
ENST00000434526.8EnsemblENSP00000400922.39MANE Select
NM_001042468.3RefSeqNP_001035933.39Standard
NM_001042469.3RefSeqNP_001035934.38Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Metabolism of lipids
  • Post-translational protein modification
  • Metabolism of proteins
  • The activation of arylsulfatases
  • Gamma carboxylation, hypusine formation and arylsulfatase activation

Biological Process

  • glycosphingolipid metabolic process
  • post-translational protein modification

Molecular Function

  • metal ion binding

Cellular Component

  • endoplasmic reticulum
  • endoplasmic reticulum lumen

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000342190
Coding exons
8
Length
16669
Individuals with no LoFs
125096
Homozygous LoFs
12
Heterozygous LoFs
639
Defined
125747
p
0.00259
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-0.5262232021.100.00001052284
Missense (PolyPhen)6456.0381.1421628
Synonymous-0.3558883.91.050.00000464727
Loss of Function0.6951417.10.8198.92e-7168

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0350.035notable
Latino/Admixed American0.00200.0020notable
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.000120.00012rare
South Asian0.000130.00013rare
Other0.00130.0013notable

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Lacks formylglycine generating activity and is unable to convert newly synthesized inactive sulfatases to their active form. Inhibits the activation of sulfatases by SUMF1. {ECO:0000269|PubMed:12757706, ECO:0000269|PubMed:15708861, ECO:0000269|PubMed:15962010}.;

Recessive Scores

pRec
0.687

Intolerance Scores

LoFtool
0.0730
RVIS EVS
0.42
RVIS percentile EVS
77.16

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.685

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.